Eli Lilly Corp. buy The Goldman Sachs Group, Inc.
Start price
13.12.25
/
50%
€881.10
Target price
13.12.26
€975.54
Performance (%)
-12.19%
Price
22:25
€773.70
Summary
This prediction is currently active. The prediction for Eli Lilly Corp. disappoints with a performance of -12.19%. This prediction currently runs until 13.12.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -2.919% | -2.919% |
| iShares Core DAX® | -0.479% | -12.062% |
| iShares Nasdaq 100 | -3.377% | -5.130% |
| iShares Nikkei 225® | -0.143% | -12.633% |
| iShares S&P 500 | -2.266% | -5.049% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $951.00 to $1,145.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat